Burcon NutraScience Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BRCNF research report →
Companywww.burcon.ca
Burcon NutraScience Corporation, together with its subsidiaries, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company's products include Peazazz, a pea protein for use in dairy alternatives, ready-to-drink beverages, dry blended beverages, bars, baked goods, and meat substitute products; and Peazac and Peazac 850, a pea protein for plant-based meat alternative products, ready-to-mix powders, ready-to-mix beverages, dairy alternatives, and nutrition bars, as well as other applications requiring the most neutral flavor and moderate viscosity. It provides Puratein, a canola protein isolate for use in meat alternatives, such as burgers, sausages, and nutrition bars; Supertein, a canola protein that is a light-colored powder for use in non-dairy frozen desserts, egg alternative, plant-based marshmallows and ready-to-mix beverages, whipped toppings, and plant-based bars; and Nutratein, a canola protein comprising a mixture of globulin and albumin proteins for use in meat and egg alternatives, and other plant-based functional foods.
- CEO
- Kip Underwood
- IPO
- 2010
- Employees
- 25
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $18.91M
- P/E
- -2.00
- P/S
- 17.39
- P/B
- -10.36
- EV/EBITDA
- -7.47
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -450.68%
- Op Margin
- -676.58%
- Net Margin
- -870.87%
- ROE
- -630.53%
- ROIC
- -46.02%
Growth & Income
- Revenue
- $381.40K · 106.88%
- Net Income
- $-8,264,787 · -10.99%
- EPS
- $-1.06 · -1629.20%
- Op Income
- $-7,699,433
- FCF YoY
- 1.49%
Performance & Tape
- 52W High
- $3.57
- 52W Low
- $1.14
- 50D MA
- $1.52
- 200D MA
- $1.52
- Beta
- 2.90
- Avg Volume
- 2.37K
Get TickerSpark's AI analysis on BRCNF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BRCNF Coverage
We haven't published any research on BRCNF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BRCNF Report →